Cn
EN
Senior Industrialization
Management Team
Core team members possess over two decades of professional expertise and senior management experience in fields including biomacromolecule drug molecular target discovery, druggability research, lab-scale and pilot process development, scale-up and translation, production process analytical technology, quality control, GMP facility construction and operation, as well as cGMP quality system management.
Solid Projects
Implementation Accumulation
Nearly 90 projects have been undertaken, covering innovative biologic drugs at IND and Phase I–III clinical stages. The company is capable of process development and documentation support complying with international registration standards including NMPA, EMA and FDA. Project delivery quality and compliance are highly recognized by clients.
-
E. coli重组蛋白冻干
-
E. coli重组蛋白BFS滴眼剂
-
E. coli重组蛋白N/A
-
CHO重组蛋白水针
-
K. phaffii重组蛋白凝胶剂
-
E. coli重组蛋白水针
-
E. coli重组蛋白N/A
-
E. coli重组蛋白冻干
-
E. coli重组蛋白凝胶剂
-
E. coli重组蛋白BFS滴眼剂
-
E. coli重组蛋白BFS滴眼剂
-
E. coli重组蛋白BFS滴眼剂
-
CHO双抗冻干
-
CHO双抗冻干/水针
-
E. coli多肽冻干
-
E. coli重组蛋白凝胶剂
-
K. phaffii重组蛋白水针
-
E. coli重组蛋白冻干
-
E. coli重组蛋白N/A
-
E. coli重组蛋白N/A
-
E. coli重组蛋白吸入剂
In-depth Industry-University-Research Collaboration
Synergistic Ecosystem
It collaborates with Wenzhou Medical University and Oujiang Laboratory to build a science-education integration platform and form a collaborative system of "University - Research Platform - Industry - Healthcare". Internship base agreements have been signed to establish an industry-education integrated talent training mechanism, providing stable talent support for achievement translation and sustainable development.
Industrial Guidance and Engineering Translation
Translation Capacity
Guided by industrial demands, it accelerates the engineering translation of research achievements through horizontal research projects, production line docking and commercial incubation. It takes the lead in establishing the Wenzhou Consortium for R&D and Industrialization of Recombinant Cell Growth Factor Innovative Medicines to jointly tackle key technologies. The whole workflow covers R&D, pilot scale-up, process optimization, large-scale manufacturing and supply of clinical samples meeting filing standards for China, the US and Europe, helping innovative medicines enter clinical practice and global markets.
